Page last updated: 2024-10-31

neostigmine and Heart Valve Diseases

neostigmine has been researched along with Heart Valve Diseases in 1 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Heart Valve Diseases: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takeuchi, E1
Murase, M1
Tanaka, M1
Hibi, M1
Yasuura, K1
Ogawa, K1
Hotta, A1
Saigusa, H1
Yoshida, K1
Abe, T1

Other Studies

1 other study available for neostigmine and Heart Valve Diseases

ArticleYear
[Replenishment of Young-GIK cardioplegia under the re-aortic cross clamp].
    [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai, 1986, Volume: 34, Issue:4

    Topics: Aorta; Citrates; Heart Arrest, Induced; Heart Valve Diseases; Humans; Hypothermia, Induced; Magnesiu

1986